It is worthwhile emphasizing that the consistent link between elevated ENO1 levels in various cancers and poor clinical outcomes highlights its essential role in triggering cancer-promoting pathways, making it an ideal candidate for therapeutic intervention (Cancemi et al., 2019). The gene discussed is ENO1; the disease is cancer.